Perceval Sutureless Aortic Valve Replacement in Aotearoa New Zealand: 10-Year Outcomes

Abstract

The contemporaneous Perceval sutureless bioprosthetic valve is utilised for surgical aortic valve replacement (AVR). Perceval valves allow for AVR with reduced cross-clamp and cardiopulmonary bypass times, which theoretically correlate with improved postoperative patient morbidity and mortality. However, there is a paucity of published literature on the long-term outcomes of Perceval AVR. This study aimed to review the long-term follow-up outcomes of Perceval AVR at a single centre in New Zealand.